Dr. Paul Billings Joins Lindus Health's Scientific Advisory Board

Lindus Health has announced the appointment of Dr. Paul Billings to its Scientific Advisory Board, strengthening its expertise in diagnostic and genomic medicine. A recognized leader in diagnostics with decades of experience across industry and clinical research, Dr. Billings will help guide Lindus Health’s strategy for designing and executing high-quality diagnostic clinical trials, supporting faster, more reliable paths from diagnostic innovation to patient impact.

This collaboration is essential to eliminating traditional barriers in patient recruitment and reducing friction when transitioning between development stages and CRO partners, ultimately accelerating the delivery of breakthrough treatments to patients.

This prestigious recognition reflects Lindus’ ongoing commitment to developing adaptive, innovative technology that fixes the broken Contract Research Organization (CRO) model through its all-in-one solution.

Heather Davis joins the executive team, bringing 30 years of experience to continue expanding Lindus Health's footprint in North America.

This collaboration strengthens Lindus’ ability to deliver robust end-to-end clinical trials through one unified solution.

Lindus Health has been able to achieve on average 72.9% faster enrollment across all their studies to date through a vertically integrated approach that breaks the status quo.